Aligos Therapeutics, Inc. — SC 13D/A Filings
5 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Aligos Therapeutics, Inc. (ALGS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aligos Therapeutics, Inc. has filed 5 SC 13D/A documents with the SEC since 2020. To view all SEC filings by Aligos Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B3
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001193125-24-028548 | Feb 8, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-023399 | Jan 31, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-195170 | Jun 21, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-195127 | Jun 21, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-148141 | May 3, 2021 | — |